Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

U.S. FDA Approves First-Ever Implant to Treat Opioid Addiction

Natalie Grover  |  May 27, 2016

(Reuters)—The first-ever implant to fight addiction to opioids, a class of drugs that includes prescription painkillers and heroin, was approved by the U.S. Food and Drug Administration on Thursday. The matchstick-sized implant, developed by Titan Pharmaceuticals Inc. and privately owned Braeburn Pharmaceuticals, is by design less susceptible to abuse or the illicit resale that plagues…

Rheumatology & Other Medical Residents Have High Risk of Depression

Richard Quinn  |  May 27, 2016

Over the past 40 years, the prevalence and risk of depression for medical residents has increased, according to research from Douglas A. Mata, MD, MPH, and colleagues. Addressing this phenomenon may be vital for the future of rheumatology and medicine…

Osteoarthritis Treatments: Monoclonal Antibody Starts Clinical Trial & Fasinumab Promising for Treating Pain

Michele B. Kaufman, PharmD, BCGP  |  May 25, 2016

Recent clinical trials have evaluated the efficacy of GSK3196165, a monoclonal antibody, and fasinumab, a nerve growth factor antibody, in treating patients with osteoarthritis and pain…

Doubts Mount over Merger of Health Insurers Anthem, Cigna

Bill Berkrot  |  May 24, 2016

(Reuters)—Wall Street expressed growing doubts about a pending $54 billion merger of U.S. health insurers Anthem Inc. and Cigna Corp. on Monday as news of management squabbles added to concerns over its review by antitrust regulators. Cigna shares closed down 4% at $126.15, well below Anthem’s original $188 per share offer of cash and stock…

Patient Can’t Always Access Complete Medical Records, Doctors Say

Lisa Rapaport  |  May 24, 2016

(Reuters Health)—Technology makes it possible for patients to access medical records online, but a thicket of legal issues may still keep people from always seeing everything in their chart, some doctors say. The Health Insurance Portability and Accountability Act (HIPAA) gives U.S. patients the right to access their medical records and control who else has…

Running Barefoot May Protect Against Some Musculoskeletal Injuries

Lara C. Pullen, PhD  |  May 23, 2016

Running barefoot may conjure images of summer and childhood, but since Abebe Bikila of Ethiopia set a world record running barefoot in the marathon in the 1960 Olympic Games in Rome (Olympic gold medal in a world-record 2:15:16.2), many runners have adopted the style. A recent study found that running barefoot may be associated with significantly fewer overall musculoskeletal injuries than running shod…

From the Expert: Dr. Michael Weisman Discusses the Challenges of Enthesitis

Richard Quinn  |  May 20, 2016

A recent review in Arthritis & Rheumatology examined advances in addressing the pathophysiology, genetics and treatment of enthesitis for patients with spondyloarthritis. And author Michael Weisman, MD, notes that challenges remain in understanding the genetics and triggers of enthesitis…

Baricitinib Has Promising Clinical Trial Results for Treating RA

Michele B. Kaufman, PharmD, BCGP  |  May 18, 2016

Recent clinical trials have shown that baricitinib is safe and effective for treating patients with rheumatoid arthritis who have proved non-responsive to multiple biologic treatments…

ABIM Announcement: Alternative MOC Assessment Starting January 2018

From the College  |  May 17, 2016

The American Board of Internal Medicine announced plans to offer a new Maintenance of Certification (MOC) assessment for internal medicine—and possibly other specialties—starting January 2018. Specific details are expected by Dec. 31, 2016, following a public comment period. The ACR will continue to push for access to clinical decision-making tools as an open-book, take-home assessment or for continuing medical education activities with assessment components to be considered appropriate options…

Autoantibodies in Pregnant Woman May Put Infant at Risk for Neonatal Lupus Erythematosus

Lara C. Pullen, PhD  |  May 16, 2016

A recent case study revealed that an infant from a donor egg developed neonatal lupus erythematosus (NLE) and a congenital heart block, which may have been due to the presence of antibodies to Ro and La in the birth mother—not the genetic mother. The results suggest that a gestational mother with a history of autoimmune disease is sufficient to trigger the pathology of NLE…

  • « Previous Page
  • 1
  • …
  • 501
  • 502
  • 503
  • 504
  • 505
  • …
  • 815
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences